Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[A case of influenza pneumonia following pneumococcal infection in an adult patient with concurrent encephalopathy with a lesion in the splenium of the corpus callosum].
Inoue Y, Hirayama T, Kondo A, Tomari S, Miyazaki T, Izumikawa K, Kakeya H, Yamamoto Y, Yanagihara K, Tashiro T, Kohno S. Inoue Y, et al. Among authors: kondo a. Kansenshogaku Zasshi. 2013 Jul;87(4):451-6. doi: 10.11150/kansenshogakuzasshi.87.451. Kansenshogaku Zasshi. 2013. PMID: 23984596 Japanese.
The efficacy and safety of sitafloxacin and garenoxacin for the treatment of pneumonia in elderly patients: A randomized, multicenter, open-label trial.
Miyazaki T, Nakamura S, Hashiguchi K, Kobayashi T, Fukushima K, Fukuda Y, Kondo A, Inoue Y, Koga H, Sasaki E, Nagayoshi Y, Higashiyama Y, Yoshida M, Takazono T, Saijo T, Morinaga Y, Yamamoto K, Imamura Y, Mikushi S, Izumikawa K, Yanagihara K, Kohno S, Mukae H. Miyazaki T, et al. Among authors: kondo a. J Infect Chemother. 2019 Nov;25(11):886-893. doi: 10.1016/j.jiac.2019.04.019. Epub 2019 May 18. J Infect Chemother. 2019. PMID: 31113725 Free article. Clinical Trial.
The efficacy and safety of high-dose arbekacin sulfate therapy (once-daily treatment) in patients with MRSA infection.
Yamamoto Y, Izumikawa K, Hashiguchi K, Fukuda Y, Kobayashi T, Kondo A, Inoue Y, Morinaga Y, Nakamura S, Imamura Y, Miyazaki T, Kakeya H, Yanagihara K, Kohno S. Yamamoto Y, et al. Among authors: kondo a. J Infect Chemother. 2012 Apr;18(2):241-6. doi: 10.1007/s10156-012-0397-4. Epub 2012 Mar 8. J Infect Chemother. 2012. PMID: 22398881 Clinical Trial.
Efficacy and safety of cefditoren pivoxil for exacerbations of chronic obstructive pulmonary disease: A prospective multicenter interventional study.
Miyazaki T, Fukushima K, Hashiguchi K, Inoue Y, Mihara T, Sawai T, Suyama N, Kobayashi T, Kondo A, Fukuda Y, Harada Y, Sasaki E, Kaku N, Ide S, Takazono T, Saijo T, Kosai K, Morinaga Y, Nakamura S, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H. Miyazaki T, et al. Among authors: kondo a. J Infect Chemother. 2019 Sep;25(9):702-707. doi: 10.1016/j.jiac.2019.03.018. Epub 2019 Apr 11. J Infect Chemother. 2019. PMID: 30982729 Free article.
Adult Still's disease associated with cytomegalovirus infection.
Izumikawa K, Morinaga Y, Kondo A, Hara K, Izumikawa K, Miyazaki Y, Kohno S, Igari N, Akaboshi M, Kawakami J, Eguchi K. Izumikawa K, et al. Among authors: kondo a. J Infect Chemother. 2007 Apr;13(2):114-7. doi: 10.1007/s10156-007-0503-1. Epub 2007 May 8. J Infect Chemother. 2007. PMID: 17458680
[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2003)].
Goto H, Takeda H, Kawai S, Nakadate T, Shimada K, Nakano K, Suwabe A, Yokouchi H, Okada S, Ashino Y, Ikemoto H, Gejyo F, Igari J, Okada M, Oguri T, Aoki N, Mori T, Yamamoto M, Kitamura N, Inoue H, Suzuki Y, Karasawa Y, Tosaka M, Kudo K, Kobayashi N, Kohno S, Tanaka T, Hirakata Y, Kondo A, Matsuda J, Nakano M, Sumitomo M, Nasu M, Niki Y, Hiramatsu K, Suga M, Suzuki Y. Goto H, et al. Among authors: kondo a. Jpn J Antibiot. 2005 Jun;58(3):326-58. Jpn J Antibiot. 2005. PMID: 16161758 Japanese.
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2003). III. Secular changes in susceptibility].
Kumamoto Y, Tsukamoto T, Matsukawa M, Kunishima Y, Watanabe K, Kobayashi Y, Uchida H, Matsuda S, Hirose T, Sato S, Shigeta S, Fujime M, Fujita K, Yamaguti O, Ishibashi K, Igari J, Suzutani T, Oguri T, Yoshida H, Imafuku Y, Yamaguchi K, Furuya N, Murai M, Deguchi T, Ishihara S, Ooe H, Matsumoto T, Takahashi K, Nishikawa M, Naito S, Egashira T, Konishi T, Oka T, Kitamura M, Kohno S, Fukuhara Y, Hirakata Y, Kondo A, Matsuda J, Nakano M, Kamidono S, Suzuki Y, Arakawa S, Kumon H, Monden K. Kumamoto Y, et al. Among authors: kondo a. Jpn J Antibiot. 2005 Dec;58(6):557-654. Jpn J Antibiot. 2005. PMID: 16521346 Japanese.
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). III. Secular changes in susceptibility].
Kumamoto Y, Tsukamoto T, Matsukawa M, Kunishima Y, Hirose T, Shigeta S, Yamaguchi O, Ishibashi K, Suzutani T, Yoshida H, Imafuku Y, Murai M, Watanabe K, Kobayashi Y, Uchida H, Matsuda S, Sato S, Fujime M, Fujita K, Igari J, Oguri T, Yamaguchi K, Furuya N, Deguchi T, Ishihara S, Ooe H, Oka T, Kitamura M, Fukuhara Y, Kamidono S, Arakawa S, Kumon H, Monden K, Matsumoto T, Muratani T, Naito S, Egashira T, Konishi T, Kohno S, Hirakata Y, Kondo A, Matsuda J, Nakano M. Kumamoto Y, et al. Among authors: kondo a. Jpn J Antibiot. 2006 Aug;59(4):217-315. Jpn J Antibiot. 2006. PMID: 17111595 Japanese.
2,179 results